NIH scientists find a novel mechanism that controls the development of autoimmunityAugust 14, 2008Scientists at the National Institutes of Health (NIH) have found a mechanism in the immune systems of mice that can lead to the development of autoimmune disease when turned off. The findings shed light on the processes that lead to the development of autoimmunity and could also have implications for the development of drugs to increase the immune response in diseases such as cancer and HIV. The study paper appears online today in the journal Nature. The scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Allergy and Infectious Diseases (NIAID), both part of the NIH, studied immune system T cells - specifically the helper T cell, an immune system component that helps other cells fight infection. They focused on the protein furin, an enzyme that plays an important role in the functioning of T cells. Scientists have been limited in their ability to study the protein furin, because other enzymes can perform some of the same functions. Also, furin is essential to life, so scientists have been unable to create a mouse without furin that lives past the embryo stage of development. Since the NIH scientists were unable to see what a mouse without furin would look like, they collaborated with Belgium scientists to create a mouse without furin only in T cells. What they discovered was that mice without furin in these cells developed systemic autoimmune disease. This means that the immune systems of the mice attacked their own cells and tissues throughout their bodies.
"We already know that furin seems to have roles in a variety of human diseases, such as cancer, cystic fibrosis and infectious diseases," says lead author Marko Pesu, Ph.D., in the NIAMS' Molecular Immunology and Inflammation Branch. "These findings show that having no furin in certain immune system cells can increase the immune response and lead to autoimmune disease in mice." The researchers found that deleting furin in helper T cells affected the functioning of two types of T cells, regulatory and effector T cells. The former cells, also called Tregs, promote immune tolerance to the body's own cells and tissues. Upon further examination, the researchers found that mice lacking furin in Tregs had lower levels of a specific protein, TGF-ß1, which is produced by these cells and is important for their ability to preserve immune tolerance. However, the researchers noted that effector T cells also produce TGF-ß1. They found that furin is also needed for TGF-ß1 production by effector T cells and that the absence of furin in effectors makes these cells more aggressive in causing autoimmune disease and tissue damage. "Inhibiting furin has been thought to reduce growth of malignant cells or to block infections by preventing essential activation of a pathogen," says study author and NIAMS' Scientific Director John J. O'Shea, M.D., chief of the NIAMS' Molecular Immunology and Inflammation Branch. "However, these results suggest that the development of drug interventions could have an unexpected side effect of increasing the risk of developing autoimmune disease." NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Malpractice Ovarian Cancer Drug Delivery Chronic Infection Chemotherapy Cholera Solar Cells Wrinkles Membrane San Andreas Fault Cardiovascular Dolphins Quantum Computers Curcumin Junk DNA Weight Gain Estrogen Receptor Saliva Oxytocin Population Growth Meteorites AIDS Terrorism Elephants Ecosystem
See More: Science News Tags | |||||||||||||||||||||
|
Related Autoimmune Disease Current Events and Autoimmune Disease News Articles New clue into how brain stem cells develop into cells which repair damaged tissue The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco (UCSF) and University of Cambridge and was published today (01 July) in the journal Genes and Development. UT researcher: Interferon alpha can delay full onset of type I diabetes A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes. Scripps research scientists find key culprits in lupus The more than 1.5 million Americans with systemic lupus erythematosus (or lupus) suffer from a variety of symptoms that flare and subside, often including painful or swollen joints, extreme fatigue, skin rashes, fever, and kidney problems. New trigger for chronic inflammation in rheumatoid arthritis discovered A signal molecule made by the human body that triggers the immune system into action may be important in rheumatoid arthritis. Aussie and Kiwi researchers make double MS genetic discovery Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease. Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus (SLE). Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients 92.8% of patients with systemic lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL). Mouse experiments shed light on age effects in arthritis Older mice are more susceptible to proteoglycan-induced arthritis (PGIA). Researchers writing in BioMed Central's open access journal Immunity & Ageing have shown, for the first time, that young mice are completely resistant, but become fully susceptible to the disease with age. Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status. One size does not fit all Statins, a commonly prescribed class of drugs used by millions worldwide to effectively lower blood cholesterol levels, may actually have a negative impact in Multiple Sclerosis (MS) patients treated with high daily dosages. More Autoimmune Disease Current Events and Autoimmune Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||